Dennis D. Kim, Chief Medical Officer at CymaBay Therapeutics, Inc. (CBAY), sold 240,000 shares at $9.54 ($2.3M) on 2023-04-17, disclosed to the SEC on 2023-04-17.
Open-market sale of $2.3M CBAY by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.98 | 7,781 | $70K | 3.1% |
| 2 | $8.98 | 7,781 | $70K | 3.1% |
| 3 | $9.54 | 112,219 | $1.1M | 46.9% |
| 4 | $9.54 | 112,219 | $1.1M | 46.9% |
| Total | $9.50 avg | 240,000 | $2.3M | 100% |
| Filing → |
| ZFGN | BUY | 2017-07-12 | $34K | — | Filing → |
| ZFGN | BUY | 2017-05-11 | $44K | — | Filing → |
| ZFGN | SELL | 2015-09-17 | $1.6M | — | Filing → |